Literature DB >> 25890655

Mesenchymal stem (stromal) cells for treatment of acute respiratory distress syndrome - authors' reply.

Jennifer Wilson1, Dave McKenna2, Kathleen D Liu1, Michael A Matthay3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25890655     DOI： 10.1016/S2213-2600(15)00040-5

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  2 in total

1.  Cellular therapies in trauma and critical care medicine: Looking towards the future.

Authors:  Shibani Pati; Todd E Rasmussen
Journal:  PLoS Med       Date:  2017-07-11       Impact factor: 11.069

2.  Feasibility and Safety of Low-Dose Mesenchymal Stem Cell Infusion in Lung Transplant Recipients.

Authors:  David Brett Erasmus; Nisha Durand; Francisco A Alvarez; Tathagat Narula; David O Hodge; Abba C Zubair
Journal:  Stem Cells Transl Med       Date:  2022-09-21       Impact factor: 7.655
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.